Global Follow-on Biologics Market Insights, Forecast to 2025

Choose Licence

 

The global Follow-on Biologics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Follow-on Biologics market based on company, product type, end user and key regions. This report studies the global market size of Follow-on Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Follow-on Biologics in these regions. This research report categorizes the global Follow-on Biologics market by top players/brands, region, type and end user. This report also studies the global Follow-on Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Sandoz Pfizer Teva Pahrmaceutical Celltrion Biocon Amgen Samsung Biologics Mylan Dr. Reddy's Laboratories Stada Arzneimittel AG Market size by Product Recombinant Non-glycosylated Proteins Recombinant Glycosylated Proteins Recombinant Peptides Market size by End User Oncology Blood Disorders Chronic Diseases Autoimmune Diseases Growth Hormone Deficiency Infectious Diseases Other Diseases Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Follow-on Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Follow-on Biologics market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Follow-on Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Follow-on Biologics submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Follow-on Biologics are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Follow-on Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Table of Contents 1 Study Coverage 1.1 Follow-on Biologics Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Follow-on Biologics Market Size Growth Rate by Product 1.4.2 Recombinant Non-glycosylated Proteins 1.4.3 Recombinant Glycosylated Proteins 1.4.4 Recombinant Peptides 1.5 Market by End User 1.5.1 Global Follow-on Biologics Market Size Growth Rate by End User 1.5.2 Oncology 1.5.3 Blood Disorders 1.5.4 Chronic Diseases 1.5.5 Autoimmune Diseases 1.5.6 Growth Hormone Deficiency 1.5.7 Infectious Diseases 1.5.8 Other Diseases 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Follow-on Biologics Market Size 2.1.1 Global Follow-on Biologics Revenue 2014-2025 2.1.2 Global Follow-on Biologics Sales 2014-2025 2.2 Follow-on Biologics Growth Rate by Regions 2.2.1 Global Follow-on Biologics Sales by Regions 2.2.2 Global Follow-on Biologics Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Follow-on Biologics Sales by Manufacturers 3.1.1 Follow-on Biologics Sales by Manufacturers 3.1.2 Follow-on Biologics Sales Market Share by Manufacturers 3.1.3 Global Follow-on Biologics Market Concentration Ratio (CR5 and HHI) 3.2 Follow-on Biologics Revenue by Manufacturers 3.2.1 Follow-on Biologics Revenue by Manufacturers (2014-2019) 3.2.2 Follow-on Biologics Revenue Share by Manufacturers (2014-2019) 3.3 Follow-on Biologics Price by Manufacturers 3.4 Follow-on Biologics Manufacturing Base Distribution, Product Types 3.4.1 Follow-on Biologics Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Follow-on Biologics Product Type 3.4.3 Date of International Manufacturers Enter into Follow-on Biologics Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Follow-on Biologics Sales by Product 4.2 Global Follow-on Biologics Revenue by Product 4.3 Follow-on Biologics Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Follow-on Biologics Breakdown Data by End User 6 North America 6.1 North America Follow-on Biologics by Countries 6.1.1 North America Follow-on Biologics Sales by Countries 6.1.2 North America Follow-on Biologics Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Follow-on Biologics by Product 6.3 North America Follow-on Biologics by End User 7 Europe 7.1 Europe Follow-on Biologics by Countries 7.1.1 Europe Follow-on Biologics Sales by Countries 7.1.2 Europe Follow-on Biologics Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Follow-on Biologics by Product 7.3 Europe Follow-on Biologics by End User 8 Asia Pacific 8.1 Asia Pacific Follow-on Biologics by Countries 8.1.1 Asia Pacific Follow-on Biologics Sales by Countries 8.1.2 Asia Pacific Follow-on Biologics Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Follow-on Biologics by Product 8.3 Asia Pacific Follow-on Biologics by End User 9 Central & South America 9.1 Central & South America Follow-on Biologics by Countries 9.1.1 Central & South America Follow-on Biologics Sales by Countries 9.1.2 Central & South America Follow-on Biologics Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Follow-on Biologics by Product 9.3 Central & South America Follow-on Biologics by End User 10 Middle East and Africa 10.1 Middle East and Africa Follow-on Biologics by Countries 10.1.1 Middle East and Africa Follow-on Biologics Sales by Countries 10.1.2 Middle East and Africa Follow-on Biologics Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Follow-on Biologics by Product 10.3 Middle East and Africa Follow-on Biologics by End User 11 Company Profiles 11.1 Sandoz 11.1.1 Sandoz Company Details 11.1.2 Company Business Overview 11.1.3 Sandoz Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Sandoz Follow-on Biologics Products Offered 11.1.5 Sandoz Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Company Business Overview 11.2.3 Pfizer Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Pfizer Follow-on Biologics Products Offered 11.2.5 Pfizer Recent Development 11.3 Teva Pahrmaceutical 11.3.1 Teva Pahrmaceutical Company Details 11.3.2 Company Business Overview 11.3.3 Teva Pahrmaceutical Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Teva Pahrmaceutical Follow-on Biologics Products Offered 11.3.5 Teva Pahrmaceutical Recent Development 11.4 Celltrion 11.4.1 Celltrion Company Details 11.4.2 Company Business Overview 11.4.3 Celltrion Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Celltrion Follow-on Biologics Products Offered 11.4.5 Celltrion Recent Development 11.5 Biocon 11.5.1 Biocon Company Details 11.5.2 Company Business Overview 11.5.3 Biocon Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Biocon Follow-on Biologics Products Offered 11.5.5 Biocon Recent Development 11.6 Amgen 11.6.1 Amgen Company Details 11.6.2 Company Business Overview 11.6.3 Amgen Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Amgen Follow-on Biologics Products Offered 11.6.5 Amgen Recent Development 11.7 Samsung Biologics 11.7.1 Samsung Biologics Company Details 11.7.2 Company Business Overview 11.7.3 Samsung Biologics Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Samsung Biologics Follow-on Biologics Products Offered 11.7.5 Samsung Biologics Recent Development 11.8 Mylan 11.8.1 Mylan Company Details 11.8.2 Company Business Overview 11.8.3 Mylan Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Mylan Follow-on Biologics Products Offered 11.8.5 Mylan Recent Development 11.9 Dr. Reddy's Laboratories 11.9.1 Dr. Reddy's Laboratories Company Details 11.9.2 Company Business Overview 11.9.3 Dr. Reddy's Laboratories Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Dr. Reddy's Laboratories Follow-on Biologics Products Offered 11.9.5 Dr. Reddy's Laboratories Recent Development 11.10 Stada Arzneimittel AG 11.10.1 Stada Arzneimittel AG Company Details 11.10.2 Company Business Overview 11.10.3 Stada Arzneimittel AG Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Stada Arzneimittel AG Follow-on Biologics Products Offered 11.10.5 Stada Arzneimittel AG Recent Development 12 Future Forecast 12.1 Follow-on Biologics Market Forecast by Regions 12.1.1 Global Follow-on Biologics Sales Forecast by Regions 2019-2025 12.1.2 Global Follow-on Biologics Revenue Forecast by Regions 2019-2025 12.2 Follow-on Biologics Market Forecast by Product 12.2.1 Global Follow-on Biologics Sales Forecast by Product 2019-2025 12.2.2 Global Follow-on Biologics Revenue Forecast by Product 2019-2025 12.3 Follow-on Biologics Market Forecast by End User 12.4 North America Follow-on Biologics Forecast 12.5 Europe Follow-on Biologics Forecast 12.6 Asia Pacific Follow-on Biologics Forecast 12.7 Central & South America Follow-on Biologics Forecast 12.8 Middle East and Africa Follow-on Biologics Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Follow-on Biologics Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Follow-on Biologics Product Picture Table Follow-on Biologics Market Segments Table Key Manufacturers Follow-on Biologics Covered Table Global Follow-on Biologics Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$) Figure Global Follow-on Biologics Sales Market Share by Product 2014-2025 Figure Recombinant Non-glycosylated Proteins Product Picture Table Major Manufacturers of Recombinant Non-glycosylated Proteins Figure Recombinant Glycosylated Proteins Product Picture Table Major Manufacturers of Recombinant Glycosylated Proteins Figure Recombinant Peptides Product Picture Table Major Manufacturers of Recombinant Peptides Table Global Follow-on Biologics Market Size Growth Rate by End User 2019-2025 (K Doses) Figure Oncology Figure Blood Disorders Figure Chronic Diseases Figure Autoimmune Diseases Figure Growth Hormone Deficiency Figure Infectious Diseases Figure Other Diseases Figure Follow-on Biologics Report Years Considered Figure Global Follow-on Biologics Market Size 2014-2025 (Million US$) Figure Global Follow-on Biologics Sales 2014-2025 (K Doses) Table Global Follow-on Biologics Market Size by Regions 2014-2019 (K Doses) & (Million US$) Table Global Follow-on Biologics Sales by Regions 2014-2019 (K Doses) Table Global Follow-on Biologics Sales Market Share by Regions 2014-2019 Figure Global Follow-on Biologics Sales Market Share by Regions 2014-2019 Figure 2018 Global Follow-on Biologics Sales Market Share by Regions Table Global Follow-on Biologics Revenue by Regions 2014-2019 (Million US$) Table Global Follow-on Biologics Revenue Market Share by Regions 2014-2019 Figure Global Follow-on Biologics Revenue Market Share by Regions 2014-2019 Figure 2018 Global Follow-on Biologics Revenue Market Share by Regions Table Global Follow-on Biologics Sales by Manufacturers (2014-2019) (K Doses) Table Global Follow-on Biologics Sales Share by Manufacturers (2014-2019) Figure Global Follow-on Biologics Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Follow-on Biologics Revenue by Manufacturers (2014-2019) (Million USD) Table Follow-on Biologics Revenue Share by Manufacturers (2014-2019) Figure Follow-on Biologics Value Share by Manufacturers in 2018 Table Key Manufacturers Follow-on Biologics Price (2014-2019) (USD/Dose) Table Follow-on Biologics Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Follow-on Biologics Product Type Table Date of International Manufacturers Enter into Follow-on Biologics Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Follow-on Biologics Sales by Product (2014-2019) (K Doses) Table Global Follow-on Biologics Sales Share by Product (2014-2019) Figure Global Follow-on Biologics Sales Market Share by Product (2014-2019) Figure Global Follow-on Biologics Sales Market Share by Product in 2018 Table Global Follow-on Biologics Revenue by Product (2014-2019) (Million US$) Table Global Follow-on Biologics Revenue Share by Product (2014-2019) Figure Global Follow-on Biologics Revenue Market Share by Product (2014-2019) Figure Global Follow-on Biologics Revenue Market Share by Product in 2018 Table Follow-on Biologics Price by Product 2014-2019 (USD/Dose) Table Global Follow-on Biologics Sales by End User (2014-2019) (K Doses) Table Global Follow-on Biologics Sales Share by End User (2014-2019) Figure Global Sales Follow-on Biologics Market Share by End User (2014-2019) Figure Global Sales Follow-on Biologics Market Share by End User in 2018 Figure North America Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses) Figure North America Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$) Table North America Follow-on Biologics Sales by Countries (2014-2019) (K Doses) Table North America Follow-on Biologics Sales Market Share by Countries (2014-2019) Figure 2018 North America Follow-on Biologics Sales Market Share by Countries Table North America Follow-on Biologics Revenue by Countries (2014-2019) (Million US$) Table North America Follow-on Biologics Revenue Market Share by Countries (2014-2019) Figure 2018 North America Follow-on Biologics Revenue Market Share by Countries Figure United States Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure United States Follow-on Biologics Revenue Growth Rate (2014-2019) (K Doses) Figure Canada Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Canada Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Mexico Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Table North America Follow-on Biologics Sales by Product (2014-2019) (K Doses) Table North America Follow-on Biologics Sales Market Share by Product (2014-2019) Figure 2018 North America Follow-on Biologics Market Share by Product Table North America Follow-on Biologics Sales by End User (2014-2019) (K Doses) Table North America Follow-on Biologics Sales Market Share by End User (2014-2019) Figure 2018 North America Follow-on Biologics Market Share by End User Figure Europe Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses) Figure Europe Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$) Table Europe Follow-on Biologics Sales by Countries (2014-2019) (K Doses) Table Europe Follow-on Biologics Sales Market Share by Countries (2014-2019) Figure 2018 Europe Follow-on Biologics Sales Market Share by Countries Table Europe Follow-on Biologics Revenue by Countries (2014-2019) (Million US$) Table Europe Follow-on Biologics Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Follow-on Biologics Revenue Market Share by Countries Figure Germany Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Germany Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure France Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure France Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure UK Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure UK Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Italy Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Russia Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Table Europe Follow-on Biologics Sales by Product (2014-2019) (K Doses) Table Europe Follow-on Biologics Sales Market Share by Product (2014-2019) Figure 2018 Europe Follow-on Biologics Market Share by Product Table Europe Follow-on Biologics Sales by End User (2014-2019) (K Doses) Table Europe Follow-on Biologics Sales Market Share by End User (2014-2019) Figure 2018 Europe Follow-on Biologics Market Share by End User Figure Asia Pacific Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses) Figure Asia Pacific Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Follow-on Biologics Sales by Countries (2014-2019) (K Doses) Table Asia Pacific Follow-on Biologics Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Follow-on Biologics Sales Market Share by Countries Table Asia Pacific Follow-on Biologics Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Follow-on Biologics Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Follow-on Biologics Revenue Market Share by Countries Figure China Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure China Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Japan Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Korea Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure India Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure India Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Australia Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Indonesia Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Malaysia Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Philippines Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Thailand Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Vietnam Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Singapore Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Follow-on Biologics Sales by Product (2014-2019) (K Doses) Table Asia Pacific Follow-on Biologics Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Follow-on Biologics Market Share by Product Table Asia Pacific Follow-on Biologics Sales by End User (2014-2019) (K Doses) Table Asia Pacific Follow-on Biologics Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Follow-on Biologics Market Share by End User Figure Central & South America Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses) Figure Central & South America Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Follow-on Biologics Sales by Countries (2014-2019) (K Doses) Table Central & South America Follow-on Biologics Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Follow-on Biologics Sales Market Share by Countries Table Central & South America Follow-on Biologics Revenue by Countries (2014-2019) (Million US$) Table Central & South America Follow-on Biologics Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Follow-on Biologics Revenue Market Share by Countries Figure Brazil Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Brazil Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Argentina Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Follow-on Biologics Sales by Product (2014-2019) (K Doses) Table Central & South America Follow-on Biologics Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Follow-on Biologics Market Share by Product Table Central & South America Follow-on Biologics Sales by End User (2014-2019) (K Doses) Table Central & South America Follow-on Biologics Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Follow-on Biologics Market Share by End User Figure Middle East and Africa Follow-on Biologics Sales Growth Rate 2014-2019 (K Doses) Figure Middle East and Africa Follow-on Biologics Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Follow-on Biologics Sales by Countries (2014-2019) (K Doses) Table Middle East and Africa Follow-on Biologics Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Follow-on Biologics Sales Market Share by Countries Table Middle East and Africa Follow-on Biologics Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Follow-on Biologics Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Follow-on Biologics Revenue Market Share by Countries Figure GCC Countries Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure GCC Countries Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Turkey Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure Egypt Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Follow-on Biologics Sales Growth Rate (2014-2019) (K Doses) Figure South Africa Follow-on Biologics Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Follow-on Biologics Sales by Product (2014-2019) (K Doses) Table Middle East and Africa Follow-on Biologics Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Follow-on Biologics Market Share by Product Table Middle East and Africa Follow-on Biologics Sales by End User (2014-2019) (K Doses) Table Middle East and Africa Follow-on Biologics Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Follow-on Biologics Market Share by End User Table Sandoz Company Details Table Sandoz Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Sandoz Recent Development Table Pfizer Company Details Table Pfizer Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Pfizer Recent Development Table Teva Pahrmaceutical Company Details Table Teva Pahrmaceutical Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Teva Pahrmaceutical Recent Development Table Celltrion Company Details Table Celltrion Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Celltrion Recent Development Table Biocon Company Details Table Biocon Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Biocon Recent Development Table Amgen Company Details Table Amgen Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Amgen Recent Development Table Samsung Biologics Company Details Table Samsung Biologics Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Samsung Biologics Recent Development Table Mylan Company Details Table Mylan Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Mylan Recent Development Table Dr. Reddy's Laboratories Company Details Table Dr. Reddy's Laboratories Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Dr. Reddy's Laboratories Recent Development Table Stada Arzneimittel AG Company Details Table Stada Arzneimittel AG Follow-on Biologics Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Stada Arzneimittel AG Recent Development Table Global Follow-on Biologics Sales Forecast by Regions 2019-2025 (K Doses) Table Global Follow-on Biologics Sales Market Share Forecast by Regions 2019-2025 Table Global Follow-on Biologics Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Follow-on Biologics Revenue Market Share Forecast by Regions 2019-2025 Table Global Follow-on Biologics Sales Forecast by Product 2019-2025 (K Doses) Table Global Follow-on Biologics Sales Market Share Forecast by Product 2019-2025 Table Global Follow-on Biologics Revenue Forecast by Product 2019-2025 (Million US$) Table Global Follow-on Biologics Revenue Market Share Forecast by Product 2019-2025 Table Global Follow-on Biologics Sales Forecast by End User 2019-2025 (K Doses) Table Global Follow-on Biologics Sales Market Share Forecast by End User 2019-2025 Figure North America Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses) Figure North America Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses) Figure Europe Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses) Figure Asia Pacific Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses) Figure Central & South America Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Follow-on Biologics Sales Growth Rate Forecast (2019-2025) (K Doses) Figure Middle East and Africa Follow-on Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Follow-on Biologics Value Chain Table Follow-on Biologics Customers List Table Follow-on Biologics Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Compressed Natural Gas (CNG) Filters Market Insights, Forecast to 2025

The Compressed Natural Gas (CNG) Filters market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as ...

Global Ceramic Infrared Heaters Market Insights, Forecast to 2025

The Ceramic Infrared Heaters market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast...

Global Carbon Infrared Heater Market Insights, Forecast to 2025

The Carbon Infrared Heater market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast p...

Global Blast Regenerative Adsorption Dryer Market Insights, Forecast to 2025

The Blast Regenerative Adsorption Dryer market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as t...

Global Adsorption Dryer Market Insights, Forecast to 2025

The Adsorption Dryer market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period ...

New Pharmaceuticals and Healthcare Reports